<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="16723">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02030509</url>
  </required_header>
  <id_info>
    <org_study_id>CSPT_ORL_2014_1</org_study_id>
    <nct_id>NCT02030509</nct_id>
  </id_info>
  <brief_title>Quick Diagnostic Program for Head and Neck Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <oversight_info>
    <authority>Spain: Spanish Agency of Medicines</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Head and neck cancer would be suitable for quick diagnostic programs because their initial
      symptoms are easy detectable and the curation rates in the initial stages are very high.

      Actually the stages at diagnosis are about 30% in initial stages and 70% in advanced stages.

      The  hypothesis of this study is that a program for quick referral of patients with symptoms
      of head and neck cancer would help early diagnosis.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">February 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only</study_design>
  <primary_outcome>
    <measure>Time from symptom onset to diagnosis</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cancer of Head and Neck</condition>
  <arm_group>
    <arm_group_label>New diagnosed patients of head and neck cancer</arm_group_label>
    <description>New diagnosed patients of head and neck cancer</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Old diagnosed head and neck cancer patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quick diagnosis program</intervention_name>
    <arm_group_label>New diagnosed patients of head and neck cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with symptoms of head and neck cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with symptoms of head and neck cancer in the Hospital reference area

        Exclusion Criteria:

          -  Patients already diagnosed when refered to Hospital
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rosa Rosell-Ferrer, PhD MD</last_name>
    <phone>937231010</phone>
    <phone_ext>21490</phone_ext>
    <email>rrosell@tauli.cat</email>
  </overall_contact>
  <location>
    <facility>
      <name>Corporacio Sanitaria Parc Tauli</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rosa Rosell-Ferrer, PhD MD</last_name>
      <phone>937231010</phone>
      <phone_ext>21490</phone_ext>
      <email>rrosell@tauli.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 7, 2014</lastchanged_date>
  <firstreceived_date>January 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corporacion Parc Tauli</investigator_affiliation>
    <investigator_full_name>Rosa Rosell Ferrer</investigator_full_name>
    <investigator_title>PhD MD</investigator_title>
  </responsible_party>
  <keyword>cancer diagnosis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
